ResearcherGeneral Hospital of Shenyang Military RegionActive in the last 2 years
Zhuo Yang
Matched on ORCID iD 0000-0002-7265-3102; OpenAlex author ID A5065843565. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2025: 3 papers
Papers 3
- FOXM1, a super enhancer-associated gene, is related to poorer prognosis and gemcitabine resistance in pancreatic cancer. Co-author DOI 10.1007/s12013-024-01653-7↗
- Correction: FOXM1, a super enhancer-associated gene, is related to poorer prognosis and gemcitabine resistance in pancreatic cancer. Co-author DOI 10.1007/s12013-025-01710-9↗
- Global, regional, and national burden of pancreatic cancer from 1990 to 2021, with projections for 25 years: a systematic analysis for the Global Burden of Dis… Last author DOI 10.1097/cej.0000000000000942↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jian Wei Jiang · 2 shared papers, 2025 · strength 0.46
- Paper FOXM1, a super enhancer-associated gene, is related to poorer prognosis and gemcitabine resistance in pancreatic cancer. DOI 10.1007/s12013-024-01653-7↗
- Paper Correction: FOXM1, a super enhancer-associated gene, is related to poorer prognosis and gemcitabine resistance in pancr… DOI 10.1007/s12013-025-01710-9↗
- Jiangning Gu · 2 shared papers, 2025 · strength 0.46
- Paper FOXM1, a super enhancer-associated gene, is related to poorer prognosis and gemcitabine resistance in pancreatic cancer. DOI 10.1007/s12013-024-01653-7↗
- Paper Correction: FOXM1, a super enhancer-associated gene, is related to poorer prognosis and gemcitabine resistance in pancr… DOI 10.1007/s12013-025-01710-9↗
- Changmiao Wang · 2 shared papers, 2025 · strength 0.46
- Paper FOXM1, a super enhancer-associated gene, is related to poorer prognosis and gemcitabine resistance in pancreatic cancer. DOI 10.1007/s12013-024-01653-7↗
- Paper Correction: FOXM1, a super enhancer-associated gene, is related to poorer prognosis and gemcitabine resistance in pancr… DOI 10.1007/s12013-025-01710-9↗
- Qihong Wang · 1 shared paper, 2025 · strength 0.42
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.